Results 241 to 250 of about 78,581 (298)

Design and computational analysis of an effective multi-epitope vaccine candidate using subunit B of cholera toxin as a build-in adjuvant against urinary tract infections. [PDF]

Bioimpacts
Rezaei M, Habibi M, Ehsani P, Asadi Karam MR, Bouzari S.   +4 more
europepmc   +1 more source

Mucosal priming of T-lymphocyte responses to fed protein antigens using cholera toxin as an adjuvant.

, 1991
Charlene Clarke, A.D. Wilson, Neil Williams, C.R. Stokes   +3 more
openalex   +1 more source

Enterotoxigenic Escherichia coli-blood group A interactions intensify diarrheal severity [PDF]

, 2018
Ciorba, Matthew A, et al,, Fleckenstein, James M, Kuhlmann, F. M, Kumar, Pardeep, Polino, Alexander, Santhanam, Srikanth, Sheikh, Alaullah, Tumala, Brunda, Vickers, Tim J   +9 more
core   +1 more source

The use of Bacillus subtilis as a cost-effective expression system for production of Cholera Toxin B fused factor VIII epitope regions applicable for inducing oral immune tolerance

Vijay Elakkya Vijayakumar, M.A. Vijayalakshmi, Sébastien Lacroix‐Desmazes, Krishnan Venkataraman   +3 more
openalex   +2 more sources

Developmental and cholera toxin-induced alterations in the expression of intracellular signalling molecules

, 2013
Lucija Zenić
openalex   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Vibrio cholerae: Cholera toxin

The International Journal of Biochemistry & Cell Biology, 2007
The bacterial protein toxin of Vibrio cholerae, cholera toxin, is a major agent involved in severe diarrhoeal disease. Cholera toxin is a member of the AB toxin family and is composed of a catalytically active heterodimeric A-subunit linked with a homopentameric B-subunit.
vanden Broeck, Davy, Horvath, Caroline A.J., de Wolf, Marc   +2 more
openaire   +3 more sources

Cholera toxin (Vibrio cholerae)

1997
Abstract CT is composed of two subunits, A and B, of 27 and 57.5 kDa respectively, held together by noncovalent interactions. The B subunit which contains the receptor binding site, is formed by five identical monomers, each of 11.5 kDa which assemble into a ring like oligomeric structure having a central hole.
M Pizza, M R Fontana, R Rappuoli
openaire   +1 more source

Preclinical pharmacology of cholera toxin

Cancer Chemotherapy and Pharmacology, 1995
Cholera toxin was selected for pharmacologic evaluation by the National Cancer Institute on the basis of antiproliferative activity against small-cell and non-small-cell lung-cancer cell lines. A feature common to the sensitive cell lines was abundant expression of GM1 ganglioside, the cellular receptor for cholera toxin.
J M, Reid, J W, Benson, J, Viallet, M M, Ames   +3 more
openaire   +2 more sources

Heterogeneity of purified cholera toxin

Biochimica et Biophysica Acta (BBA) - Protein Structure, 1977
The heterogeneity of Vibrio cholerae toxin, obtained from culture filtrates in homogeneous form by gel filtration and preparative disc gel electrophoresis has been studied. By means of disc electrophoresis on polyacrylamide gel cholera toxin was separated into three forms designated I (5%), II (15%) and III (80%). The toxic activity, amino acid content
L G, Roda, M, Tomasi, A, Battistini, I, Luzzi, P, Mastrantonio, A, Zampieri, G, D'Agnolo   +6 more
openaire   +2 more sources